2019 Innovations in Stem Cells, Cellular Therapies, Diabetes Therapy, Gene Therapies, Antiaging Research, Biomarkers, and Vaccines – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Innovations
in Stem Cells, Cellular Therapies, Diabetes Therapy, Gene Therapies,
Antiaging Research, Biomarkers, and Vaccines” report has been
added to ResearchAndMarkets.com’s offering.

The Life Science, Health & Wellness TechVision Opportunity Engine (TOE)
comprises analytical insights across various innovations.

The TOE describes disruptive technological developments across stem cell
platforms, personalized medicine, use of artificial intelligence for
Alzheimer’s disease, gene therapies, melanoma management, biomarkers,
vaccines, liver cancer management, monoclonal antibodies, and the
management of post-partum depression.

Key Topics Covered

1. Celularity
2. Rubius Therapeutics
3. Magenta Therapeutics
4. Semma Therapeutics
5. Orig3n
6. University of California San Francisco (UCSF)
7. UCSF
8. MeiraGTx
9. Boston University School of Medicine
10. Gero
11. Epitopoietic Research Corporation
12. Provention Bio
13. Sage Therapeutics
14. Basilea Pharmaceutica
15. Exelixis
16. NYU
17. University of Washington
18. Roslin Institute Features of chicken eggs as bioreactors
19. ESCO Aster
20. Agenus
21. Indian Institute of Technology, Mandi
22. Liverpool School of Tropical Medicine
23. University of Chicago
24. UroGen
25. Unity Biotechnology
26. Bruin Biometrics
27. Teva Pharmaceutical Industries
28. Key Contacts

For more information about this report visit https://www.researchandmarkets.com/research/tfgwlr/2019_innovations?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Stem
Cells, Biomarkers,
Vaccines,
Endocrinology